Long‐term safety and efficacy of canagliflozin as add‐on therapy to teneligliptin in Japanese patients with type 2 diabetes

AIM: To evaluate the long‐term safety and efficacy of canagliflozin as add‐on therapy in patients with type 2 diabetes mellitus (T2DM) who had inadequate glycaemic control with teneligliptin monotherapy. METHODS: This open‐label 52‐week study was conducted in Japan. Patients received canagliflozin 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Kadowaki, Takashi, Inagaki, Nobuya, Kondo, Kazuoki, Nishimura, Kenichi, Kaneko, Genki, Maruyama, Nobuko, Nakanishi, Nobuhiro, Watanabe, Yumi, Gouda, Maki, Iijima, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724659/
https://www.ncbi.nlm.nih.gov/pubmed/28608617
http://dx.doi.org/10.1111/dom.13038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724659/
https://www.ncbi.nlm.nih.gov/pubmed/28608617
http://dx.doi.org/10.1111/dom.13038

Ejemplares similares